Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Total Non-Current Liabilities: 2015-2020

Historic Total Non-Current Liabilities for Outlook Therapeutics (OTLK) over the last 4 years, with Jun 2020 value amounting to $19.1 million.

  • Outlook Therapeutics' Total Non-Current Liabilities fell 37.57% to $19.1 million in Q2 2020 from the same period last year, while for Jun 2020 it was $19.1 million, marking a year-over-year decrease of 37.57%. This contributed to the annual value of $24.0 million for FY2019, which is 39.46% down from last year.
  • Latest data reveals that Outlook Therapeutics reported Total Non-Current Liabilities of $19.1 million as of Q2 2020, which was down 43.23% from $33.6 million recorded in Q1 2020.
  • In the past 5 years, Outlook Therapeutics' Total Non-Current Liabilities registered a high of $48.9 million during Q3 2017, and its lowest value of $19.1 million during Q2 2020.
  • Its 3-year average for Total Non-Current Liabilities is $33.4 million, with a median of $35.2 million in 2018.
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first crashed by 54.81% in 2016, then skyrocketed by 73.71% in 2017.
  • Over the past 5 years, Outlook Therapeutics' Total Non-Current Liabilities (Quarterly) stood at $38.1 million in 2016, then dropped by 1.40% to $37.6 million in 2017, then dropped by 2.22% to $36.8 million in 2018, then dropped by 13.26% to $31.9 million in 2019, then slumped by 37.57% to $19.1 million in 2020.
  • Its last three reported values are $19.1 million in Q2 2020, $33.6 million for Q1 2020, and $31.9 million during Q4 2019.